Why financial hardship is more likely if you’re disabled or sick 
Rubio Discusses Iran Crisis and Strait of Hormuz Disruptions With UK and Australia 
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
Trump Says Iran Ceasefire ‘On Life Support’ as Oil Prices Surge Above $104 
Can your cat recognise you by scent? New study shows it’s likely 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Gold Prices Hold Firm as Traders Watch U.S.-Iran Ceasefire and Trump-Xi Talks 
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs 
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says 
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO 
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back 
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
Yes, government influences wages – but not just in the way you might think 
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook 
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
